The U.S. Treasury put Fannie Mae (FNMA) and Freddie Mac (FMCC) into a financial limbo called ‘conservatorship’ in 2008 at the height of the financial crisis. President Obama and the slew of candidates seeking to succeed him may be avoiding this highly partisan topic, but American investors should not because the fate of these entities directly affects their portfolios, said Bethany McLean, author of Shaky Ground. 'The mortgage-backed securities that they issue, it is debt backed by the mortgages of Americans and there is about $5 trillion of it outstanding today,' said McLean. 'It moves through the global capital markets like water. It’s everywhere.' McLean is the co-author of the bestseller The Smartest Guys in the Room: The Amazing Rise and Scandalous Fall of Enron with her Fortune magazine colleague Peter Elkind. She also co-authored All the Devils are Here: The Hidden History of the Financial Crisis along with NY Times columnist Joe Nocera. McLean said these government sponsored entities (GSE) have been political pariahs because capitalists and free-market proponents do not want the government playing a role in the housing market. Some claim that the pair caused the housing crisis. She added that Fannie and Freddie executives have historically been richly rewarded, turning the companies into political footballs. Simply put, McLean said Fannie and Freddie’s decisions to dive into the subprime mortgage world at exactly the wrong time doomed them to bankruptcy.
More from Video
Amid the Selling, Here's the Big Question Now
How quickly do we find support, is what we'll want to know now, as the correction is occurring while economic optimism builds.
One Tweet Pulls the Rug Out From Under the Indexes
Despite the president's promise of no stimulus until after Nov. 3, there are no signs yet that this is the sort of correlated selling that leads to a deep correction.
A Technical Look at the New Dow Jones Industrial Average
Salesforce, Amgen and Honeywell will give a lift to the DJIA going forward.
Conagra Brands Looks Tastier After Its Upgrade to Buy
CAG has hung onto the bulk of its recent gains, and could rise to the $50 area, according to the charts and indicators.
Biogen Bulls Get a Lift From Quant Upgrade and Strengthening Charts
Breaking down an approach to the long side of this biotech stock.
Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation.
If you have questions, please contact us here.